Beyond objective clinical outcomes, GI motility disturbances can substantially affect patient-reported outcomes, including daily functioning, dietary intake, and overall quality of life
Follow-Up and Monitoring We schedule follow-up appointments to track your body composition changes, assess progress, and adjust your protocol as needed
Sources European Society of Cardiology, Obesity and Cardiovascular Disease: Clinical Consensus Statement European Medicines Agency, Wegovy (semaglutide) European Medicines Agency, Mounjaro (tirzepatide) European Medicines Agency, Ozempic (semaglutide) February 12, 2026 March 10, 2026 Start your weight loss journey with Yazen today Everything you need to do is to create an account and answer some questions about your health More articles Contraceptives and weight loss medications: How Wegovy and Mounjaro can affect the efficacy of birth control pills When treating with weight loss medications like Wegovy (semaglutide) and Mounjaro (tirzepatide), it is important to consider how the medications can affect fertility and the efficacy of contraceptives
A patient may have an upset stomach or a rash at the injection area, but these were not prolonged or required additional treatment